2DG: Dr Reddy’s Releases Important Information Regarding Anti-COVID-19 Drug Developed by DRDO; Commercial Launch & Supply to Commence in Mid-June
Dr Reddy’s on Wednesday released important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories. The anti-COVID-19 drug is expected to lunch commercially in mid-June.
Dr Reddy’s Releases Important Information Regarding DRDO Developed 2DG; Commercial Launch & Supply to Commence in Mid-June
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)